Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by BlueJays9293on Feb 22, 2024 2:07am
246 Views
Post# 35892539

What's all the kerfuffle about?

What's all the kerfuffle about?Vague PR yes, maybe some more color in the morning hopefully, but as it stands we now have enough cash to get us thru May.

Which means our bridge to the July warrants and the 6mm CAD into Spectrals coffers, is now down to just a mere two months.

Funny how Vantive is also going spinco IPO in July.

It's purely coincidence, but Baxter's July Vantive deadline is much more profound financially than Spectral having to do a simple 2 month bridge financing.

Vantive IPO with PMX, will be several hundred million dollars more at pricing than it will be without PMX.

I've said it before and I'll say it again, Vantive is a dead fish without PMX/EAA.

And I'll add, Oxiris is a fish out of water flopping around on the shore without piggy backing onto PMX/EAA.

PMX is the commercial mop that cleans up a huge mess from your septic tank, and Oxiris is just a swifter that makes things look all nice before your house guest arrive.

Today's PR sort of feels like a Jeff Boras comment to the media as negotiations are still on going and deep.

Who flinches first for the whole enchilada is anybodies guess, 

but if I was a betting man, I'd bet on the guy that just has to do a bridge to keep on keeping on, versus the behemoth dinasaur trying to convince institutional investors/pension funds and analyst at the big houses, that it is, and will become again, an innovator with growth potential.  Like it used to be many years ago.




<< Previous
Bullboard Posts
Next >>